Under Armour cuts revenue forecast; federal probe weighs on shares
(Reuters) – Under Armour Inc (UA.N) (UAA.N) on Monday cut its forecast for annual revenue for a second time this year, the latest sign of problems for the sportswear maker…
Encana plans move to the U.S., changes name
FILE PHOTO: Encana offices is pictured in Parachute, Colorado, U.S. on December 10, 2014. REUTERS/Jim Urquhart/File Photo (Reuters) – Canadian oil and gas producer Encana Corp (ECA.TO) said on Thursday…
Lyft sees ‘path to profitability’ as riders, revenues increase
(Reuters) – Ride-hailing company Lyft Inc (LYFT.O) on Wednesday said higher-than-expected third-quarter revenues and an improved outlook showed it was well on its way to profitability by the end of…
Amgen posts higher biosimilar sales, ends neuroscience program
(Reuters) – Amgen Inc on Tuesday said competition for its older drugs sent third-quarter revenue down 3%, but biosimilar sales were strong and the quarterly results were ahead of Wall…
Indonesia report on 737 MAX crash faults Boeing design, says Lion Air made mistakes
JAKARTA (Reuters) – Boeing (BA.N), acting without adequate oversight from U.S. regulators, failed to grasp risks in the design of cockpit software on its 737 MAX airliner, sowing the seeds…
McDonald’s posts rare profit miss, shares drop
(Reuters) – McDonald’s Corp (MCD.N) missed Wall Street estimates for profit for the first time in two years on Tuesday as more investment to spruce up U.S. restaurants and speed…
IBM revenue misses on weakness in its biggest unit; shares fall 5%
(Reuters) – International Business Machines Corp (IBM.N) missed Wall Street estimates for quarterly revenue on Wednesday, as its global technology services unit was hit by weakness in some European markets,…
Netflix shares jump as subscribers grow ahead of Disney, Apple attack
(Reuters) – Netflix Inc (NFLX.O) added slightly more paying subscribers than Wall Street expected in the third quarter, a relief to investors who had worried the company might fall short…
Embattled drugmaker Indivior raises forecasts on Suboxone strength
(Reuters) – Indivior Plc on Tuesday raised its full-year forecasts as the embattled British drugmaker’s best-selling opioid addiction drug Suboxone fared better than expected in the face of competition from…
Capital spending outlook another worry ahead of earnings
NEW YORK (Reuters) – Investors are preparing for more cautious capital investment outlooks from U.S. companies as worries mount heading into earnings season about the possibility of an economic recession.…